Refine
Document Type
- Doctoral Thesis (3)
Has Fulltext
- yes (3)
Is part of the Bibliography
- no (3)
Keywords
- CAD (3) (remove)
Ebolaviruses are zoonotic pathogens causing severe hemorrhagic fevers in humans
and non-human primates with high case fatality rates. In recent years, the number and
scope of outbreaks has increased, highlighting the importance of better understanding
the molecular aspects of ebolaviral infection and host cell interactions in order to be able to better control this virus.
To facilitate virus genome replication, transcription and protein expression,
ebolaviruses recruit and interact with specific host factors. These interactions play a key role in viral infection and influence virus survival and disease outcome. Based on a genome-wide siRNA screen, the three host factors CAD, NXF1 and UAP56 were
recently identified to be involved in ebolavirus genome replication and/or transcription
and/or mRNA-translation. However, mechanistical details of how these host factors
affect the ebolavirus lifecycle remained elusive.
In this thesis I analyzed the functional interactions between EBOV and these newly
identified host proteins in order to better understand the virus-host interface. To this
end I used siRNA knockdown as well as overexpression of these host proteins in
combination with different reverse-genetics based lifecycle modelling assays to
investigate the influence of CAD, NXF1 and UAP56 on individual aspects of the EBOV
lifecycle. Using these systems in relation with a host factor knockdown I was able to
show that the provision of pyrimidines by CAD plays an important role for both EBOV
genome replication and transcription, whereas NXF1 is predominantly required for
mRNA transport. I furthermore used immunofluorescence analysis to examine whether
these host factors are recruited by one or more EBOV proteins to inclusion bodies,
which represent physical sites of ebolavirus genome replication. During these
experiments, I was able to show that CAD and NXF1, and possibly also UAP56, are
recruited to EBOV inclusion bodies in order to fulfill their individual function for EBOV RNA synthesis or later steps in protein expression. Additionally, I was able to show that the uptake of NXF1 into NP-induced inclusion bodies is most likely mediated via the C-terminal domain of NP, and that the FG-repeat interaction domains of NXF1 are sufficient for recruitment. Further, my data indicate that RNA interaction of both NXF1 and NP is not required for this process, but rather important for exit of NXF1 from inclusion bodies. I therefore suggest that the viral mRNA is transferred in inclusionbodies from NP to NXF1, which leads to a rapid export of the NXF1 packed viral mRNA into the cytosol for mRNA translation.
The exact mechanism of how these host factors are recruited into inclusion bodies and whether they have similar functions in the lifecycle of other negative-sense RNA viruses still needs to be investigated. Nevertheless, this study increases our understanding of virus-host interaction of ebolaviruses, and thus helps to identify targets for the development of novel therapeutics against these viruses.